Vanguard Group Inc Inmune Bio, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 541,329 shares of INMB stock, worth $4.77 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
541,329
Previous 541,329
-0.0%
Holding current value
$4.77 Million
Previous $6.1 Million
4.35%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding INMB
# of Institutions
57Shares Held
2.88MCall Options Held
44.6KPut Options Held
3.5K-
Black Rock Inc. New York, NY240KShares$2.12 Million0.0% of portfolio
-
Mai Capital Management181KShares$1.6 Million0.02% of portfolio
-
Rhenman & Partners Asset Management Ab Stockholm, V7178KShares$1.57 Million0.2% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$1.51 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny159KShares$1.4 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $158M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...